109 related articles for article (PubMed ID: 26666511)
21. High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker.
Hiraoka K; Hida Y; Miyamoto M; Oshikiri T; Suzuoki M; Nakakubo Y; Shinohara T; Itoh T; Shichinohe T; Kondo S; Kasahara N; Katoh H
Int J Cancer; 2002 May; 99(3):418-23. PubMed ID: 11992411
[TBL] [Abstract][Full Text] [Related]
22. [The prognostic factors of pancreatic cancer--adhesion molecule CD44].
Gotoda T; Matsumura Y; Kokawa A; Kondo H
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2036-42. PubMed ID: 9838904
[TBL] [Abstract][Full Text] [Related]
23. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
[TBL] [Abstract][Full Text] [Related]
25. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
27. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
28. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
[TBL] [Abstract][Full Text] [Related]
29. Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma.
Tobita K; Kijima H; Dowaki S; Oida Y; Kashiwagi H; Ishii M; Sugio Y; Sekka T; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Oncol; 2002 Dec; 21(6):1189-95. PubMed ID: 12429967
[TBL] [Abstract][Full Text] [Related]
30. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
31. Phosph-Akt1 expression is associated with a favourable prognosis in pancreatic cancer.
Liu J; Cheng Sun SH; Sun SJ; Huang C; Hu HH; Jin YB; Qiu ZJ
Ann Acad Med Singap; 2010 Jul; 39(7):548-7. PubMed ID: 20697673
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
33. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C
PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486
[TBL] [Abstract][Full Text] [Related]
34. Decreased RGS6 expression is associated with poor prognosis in pancreatic cancer patients.
Jiang N; Xue R; Bu F; Tong X; Qiang J; Liu R
Int J Clin Exp Pathol; 2014; 7(7):4120-7. PubMed ID: 25120791
[TBL] [Abstract][Full Text] [Related]
35. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
36. Akt and Cks1 are related with lymph node metastasis in gastric adenocarcinoma.
Lee SW; Kang SB; Lee DS; Lee JU
Hepatogastroenterology; 2013 Jun; 60(124):932-7. PubMed ID: 23321124
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer.
Sasada T; Azuma K; Hirai T; Hashida H; Kanai M; Yanagawa T; Takabayashi A
Ann Surg Oncol; 2008 Feb; 15(2):609-17. PubMed ID: 18026799
[TBL] [Abstract][Full Text] [Related]
38. [Expression of TFPI-2 gene in pancreatic carcinoma and its prognostic significance].
Tang ZG; Sun ZY; Hu HJ; Xu GL; Chen J; Li JS
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):598-601. PubMed ID: 19102937
[TBL] [Abstract][Full Text] [Related]
39. [Expression of miR-216a in pancreatic cancer and its clinical significance].
Hou B; Jian Z; Chen S; Ou Y; Li S; Ou J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1628-31. PubMed ID: 23174591
[TBL] [Abstract][Full Text] [Related]
40. CD44 isoforms expression in intraductal and invasive pancreatic cancer and its correlation to p53 gene mutations.
Tomaszewska R; Nowak K; Stachura J
Pol J Pathol; 1999; 50(3):145-53. PubMed ID: 10624116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
